Production (Stage)
Citius Oncology, Inc.
CTOR
$1.39
-$0.08-5.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -69.69% | -65.09% | -65.09% | 29.37% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 102.54% | 120.84% | 41.81% | 29.37% | -- |
|
|
|||||
| Total Current Assets | 102.54% | 120.84% | 41.81% | 29.37% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 83.50% | 83.50% | 83.50% | 0.00% | -- |
| Total Assets | 86.97% | 89.55% | 76.74% | 4.76% | -- |
|
|
|||||
| Total Accounts Payable | 1,423.38% | 2,765.66% | 187.94% | -- | -- |
| Total Accrued Expenses | -49.61% | -61.18% | -97.02% | 87.99% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 80.09% | 83.02% | 55.37% | 74.70% | -- |
|
|
|||||
| Total Current Liabilities | 80.09% | 83.02% | 55.37% | 74.70% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.70% | 53.72% | 50.00% | 57.14% | -- |
| Total Liabilities | 92.00% | 96.69% | 72.21% | 73.77% | -- |
|
|
|||||
| Common Stock & APIC | 87.88% | 91.36% | 95.62% | 18.70% | -- |
| Retained Earnings | -93.82% | -100.98% | -116.65% | -150.85% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 79.59% | 81.69% | 80.69% | -40.78% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 79.59% | 81.69% | 80.69% | -40.78% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 79.59% | 81.69% | 80.69% | -40.78% | -- |
|
|
|||||